La Rosa Holdings Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by La Rosa Holdings Corp. (Nevada) on May 27, 2026. The filing discloses the entry into a Material Definitive Agreement and the unregistered sale of equity securities. The Company is an emerging growth company listed on The Nasdaq Stock Market LLC under the symbol LRHC.
Key Financial Metrics and Transaction Details
The filing details a capital raise through the issuance of Series D Convertible Preferred Stock rather than reporting standard operating financial metrics such as revenue or net income.
- Transaction Type: Securities Purchase Agreement (SPA) for Series D Convertible Preferred Stock.
- Initial Closing: 250 shares issued on May 27, 2026, for an aggregate purchase price of $250,000 ($1,000 per share).
- Commitment: The Investor may purchase an additional 250 shares (total 500 shares) at its sole option upon the filing of the Company's 10-K for the year ended December 31, 2025.
- Dividends: The Series D Preferred Stock bears no dividends.
- Conversion Price: $1.58 per share (subject to adjustment) or an Alternate Conversion Price based on the lowest VWAP of the Common Stock over a 10-day period (subject to a floor and multipliers).
Material Changes and Terms
The primary material change is the creation of a new class of equity with specific rights and preferences:
- Voting Rights: Limited to specific corporate actions that adversely affect the Series D stock, such as amendments to the Certificate of Incorporation, creation of senior stock, or repurchases of junior stock.
- Anti-Dilution Protection: The Conversion Price is subject to downward adjustment if the Company issues Common Stock or convertible securities at an effective price lower than the current Conversion Price.
- Ownership Cap: Conversion is restricted if the holder would beneficially own more than 9.99% of the Common Stock post-conversion.
- Redemption: The Company has the right to redeem all outstanding shares at the greater of the Conversion Amount or the product of the Conversion Rate and the highest Closing Sale Price of Common Stock during a specified period.
Guidance, Risks, and Contingencies
The filing does not provide forward-looking guidance, revenue outlook, or management commentary regarding operational performance. Key contingencies and risks include:
- Future Issuance: The remaining 250 shares are contingent on the Investor's option following the 2025 Annual Report filing.
- Dilution Risk: The anti-dilution provisions may significantly increase the number of common shares issuable upon conversion if the Company raises capital at lower prices in the future.
- Regulatory Exemption: The sale was conducted under Rule 506(b) of Regulation D, exempting it from registration requirements.
Investor Verification Checklist
- Verify the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and conditions not summarized here.
- Review the Certificate of Designation (Exhibit 3.1) to confirm the exact definitions of "Floor Price," "Change of Control," and adjustment mechanisms.
- Confirm the Company's current Common Stock trading price to assess the immediate dilution impact of the $1.58 conversion price.
- Monitor the filing of the 2025 Form 10-K to determine if the Investor exercises the option for the remaining 250 shares.